SCHEMBL30950217

SCHEMBL30950217

Cc1ccc2[nH]ncc2c1Oc1cccc2c(N3CCN(C(=O)OC(C)(C)C)CC3)c(C#N)c(Cl)nc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNH2 Q12809 1/20 0.35
▸ CCNK O75909 1/20 0.35
▸ CCNA2 P20248 1/20 0.35
▸ CDK2 P24941 1/20 0.35
▸ CCND3 P30281 1/20 0.35
▸ CDK9 P50750 1/20 0.35
▸ CDK6 Q00534 1/20 0.35
▸ TRPV1 Q8NER1 3/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ SQOR Q9Y6N5 1/20 0.34
▸ GPR119 Q8TDV5 2/20 0.34
▸ RET P07949 1/20 0.33
▸ NR1H2 P55055 1/20 0.33
▸ NR1H3 Q13133 1/20 0.33
▸ GBA1 P04062 1/20 0.33
▸ CKS1B P61024 1/20 0.33
▸ SKP1 P63208 1/20 0.33
▸ SKP2 Q13309 1/20 0.33
▸ POLB P06746 1/20 0.33
▸ NSD2 O96028 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28655570 1.00 KCNH2 (0.35) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL30950272 0.92 KCNH2 (0.36) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL28929882 0.92 KCNH2 (0.36) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL28664682 0.91 KCNH2 (0.36) KCNH2SQORGPR119RETNR1H2
SCHEMBL30950196 0.91 KCNH2 (0.36) KCNH2SQORGPR119RETNR1H2
SCHEMBL28654715 0.90 KCNH2 (0.35) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL30950231 0.90 KCNH2 (0.35) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL30950243 0.89 KRAS (0.38) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL28673619 0.89 KRAS (0.38) KCNH2CCNKCCNA2CDK2CCND3
SCHEMBL30950264 0.88 KRAS (0.42) KCNH2PARP1SQORGPR119RET

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113637005-B KRAS inhibitors for cancer treatment 泰励生物科技(上海)有限公司 2024-05-24 — — CN disclosed
Send feedback